Is Solventum Corporation (SOLV) A Good Stock To Buy Now?
Is SOLV a good stock to buy? We came across a bullish thesis on Solventum Corporation on r/ValueInvesting by raytoei. In this article, we will summarize the bulls’ thesis on SOLV.
Solventum Corp (SOLV)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Trian Partners Nelson Peltz | 8,236,753 | $537,859,971 | 13.93% | |
| 2. | Diamond Hill Capital Ric Dillon | 2,420,246 | $158,042,064 | +15% | 0.99% |
| 3. | Madison Avenue Partners Eli Samaha | 1,875,736 | $122,485,561 | -6% | 5.33% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 883,534 | $57,694,770 | -9% | 0.03% |
| 5. | AQR Capital Management Cliff Asness | 730,045 | $47,219,279 | +56% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $68.03 | 1,475 | $100,344.25 | 5,039 | 2026-03-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $73.45 | 8,800,000 | $646,360,000.00 | 25,569,190 | 2025-08-15 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 379,356 | $29,267,315 | 0.48% | |
| 2. | 41,898 | $3,232,431 | 0.02% | |
| 3. | 9,090 | $701,294 | 0.02% | |
| 4. | 8,820 | $680,463 | 0.09% | |
| 5. | 8,327 | $642,429 | 0.02% |
News See All
Solventum Corporation (SOLV) Fell as Its HCIT Unit Hurt by AI Disruption Fears
Cambiar SMID Fund, managed by Cambiar Investors, published its Q1 2026 investor letter. A copy of the letter is available to download here.
Solventum Corporation (NYSE:SOLV) Q1 2026 Earnings Call Transcript
Operator: Hello, and welcome to Solventum Corporation's first quarter fiscal year 2026 earnings call. All lines have been placed on mute to prevent any background noise.
Solventum (SOLV) Rated Buy by Jefferies After Earnings Beat
Solventum Corporation (NYSE:SOLV) ranks among the recent spin-off companies that hedge funds are piling into.
10 Recent Spin-off Companies That Hedge Funds Are Piling Into
Spin-offs enable businesses to reduce operational burdens and focus on their most strategic options.
Solventum (SOLV) Q4 2025 Adjusted Diluted EPS Reaches $1.57 on 3.5% Organic Sales Growth
Solventum Corporation (NYSE:SOLV) is one of the cheap new stocks to buy now.
12 Cheap New Stocks to Buy Now
Earlier on February 19, Ryan Detrick, chief market strategist at Carson Group, joined BNN Bloomberg to discuss his optimistic outlook for North American markets and attributed his bullishness to a spectacular...
Solventum Corporation (NYSE:SOLV) Q4 2025 Earnings Call Transcript
Operator: Good afternoon. My name is Audra, and I will be your conference call operator today. I would like to welcome everyone to Solventum's Fourth Quarter 2025 Earnings Call.
Mizuho Upgrades Solventum (SOLV), Cites Optimistic Dental Outlook, Acera Acquisition
Solventum Corporation (NYSE:SOLV) is one of the most profitable new stocks to buy right now.
7 Most Profitable New Stocks to Buy Right Now
On January 21, Lynn Martin, the President of the NYSE, joined the Davos 2026 coverage to discuss a robust outlook for global capital markets and describe 2026 as a potential super cycle for IPO activity...
Hedge Fund Resource Center